Pseudo-vitamin D deficiency

Vitamin D

Volumn , Issue , 2011, Pages 1187-1195

  Glorieux, Francis H ^a   Edouard, Thomas ^a   St Arnaud, René ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873998982     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10064-2     Document Type: Chapter

References (37)

1. Fraser D., Salter R.B. The diagnosis and management of the various types of rickets. Pediatr. Clin. North Am. 1958, 417-441.
2. Royer P. [Study on idiopathic hypophosphatemic vitamin-resistant rickets.]. Acta Clin. Belg. 1960, 15:499-517.
3. Prader A., Illig R., Heierli E. [An unusual form of primary vitamin D-resistant rickets with hypocalcemia and autosomal-dominant hereditary transmission: hereditary pseudo-deficiency rickets.]. Helv. Paediatr. Acta 1961, 16:452-468.
4. Scriver C.R. Vitamin D dependency. Pediatrics 1970, 45:361-363.
5. Fraser D., Kooh S.W., Kind H.P., Holick M.F., Tanaka Y., DeLuca H.F. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N. Engl. J. Med. 1973, 289:817-822.
6. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L. Portale AA 1997 Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 1997, 11:1961-1970.
7. Marx S.J., Spiegel A.M., Brown E.M., Gardner D.G., Downs R.W., Attie M., et al. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 1978, 47:1303-1310.
8. Rosen J.F., Fleischman A.R., Finberg L., Hamstra A., DeLuca H.F. Rickets with alopecia: an inborn error of vitamin D metabolism. J. Pediatr. 1979, 94:729-735.
9. Hughes M.R., Malloy P.J., Kieback D.G., Kesterson R.A., Pike J.W., Feldman D., et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988, 242:1702-1705.
10. Ladhani S., Srinivasan L., Buchanan C., Allgrove J. Presentation of vitamin D deficiency. Arch. Dis. Child 2004, 89:781-784.
11. Edouard T., Alos N., Chabot G., Roughley P., Glorieux F.H., Rauch F. Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J. Clin. Endocrinol. Metab. 2011, 96:82-89.
12. Arnaud C., Maijer R., Reade T., Scriver C.R., Whelan D.T. Vitamin D dependency: an inherited postnatal syndrome with secondary hyperparathyroidism. Pediatrics 1970, 46:871-880.
13. Rosen J.F., Finberg L. Vitamin D-dependent rickets: actions of parathyroid hormone and 25-hydroxycholecalciferol. Pediatr. Res. 1972, 6:552-562.
14. Delvin E.E., Glorieux F.H., Marie P.J., Pettifor J.M. Vitamin D dependency: replacement therapy with calcitriol?. J. Pediatr. 1981, 99:26-34.
15. Scriver C.R., Reade T.M., DeLuca H.F., Hamstra A.J. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N. Engl. J. Med. 1978, 299:976-979.
16. Mandla S., Jones G., Tenenhouse H.S. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases. J. Clin. Endocrinol. Metab. 1992, 74:814-820.
17. Arabian A., Grover J., Barre M.G., Delvin E.E. Rat kidney 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylases: evidence for two distinct gene products. J. Steroid Biochem. Mol. Biol. 1993, 45:513-516.
18. Bouchard G., Laberge C., Scriver C.R. [Hereditary tyrosinemia and vitamin-dependent rickets in Saguenay. A genetic and demographic approach]. Union Med. Can. 1985, 114:633-636.
19. De Braekeleer M., Larochelle J. Population genetics of vitamin D-dependent rickets in northeastern Quebec. Ann. Hum. Genet. 1991, 55:283-290.
20. Labuda M., Labuda D., Korab-Laskowska M., Cole D.E., Zietkiewicz E., Weissenbach J., et al. Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am. J. Hum. Genet. 1996, 59:633-643.
21. De Braekeleer M. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada). Hum. Hered. 1991, 41:141-146.
22. Shinki T., Shimada H., Wakino S., Anazawa H., Hayashi M., Saruta T., et al. Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 1997, 94:12920-12925.
23. St-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., Glorieux F.H. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res. 1997, 12:1552-1559.
24. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J. Kato S 1997 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D. synthesis Science 1997, 277:1827-1830.
25. Kitanaka S., Takeyama K., Murayama A., Sato T., Okumura K., Nogami M., et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Engl. J. Med. 1998, 338:653-661.
26. Yoshida T., Monkawa T., Tenenhouse H.S., Goodyer P., Shinki T., Suda T., et al. Two novel 1alpha-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type II. Kidney Int. 1998, 54:1437-1443.
27. Kim C.J., Kaplan L.E., Perwad F., Huang N., Sharma A., Choi Y., et al. Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 2007, 92:3177-3182.
28. Wang X., Zhang M.Y., Miller W.L., Portale A.A. Novel gene mutations in patients with 1alpha-hydroxylase deficiency that confer partial enzyme activity in vitro. J. Clin. Endocrinol. Metab. 2002, 87:2424-2430.
29. Wang J.T., Lin C.J., Burridge S.M., Fu G.K., Labuda M., Portale A.A., et al. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am. J. Hum. Gene 1998, 63:1694-1702.
30. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
31. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98:7498-7503.
32. Hamilton R., Harrison J., Fraser D., Radde I., Morecki R., Paunier L. The small intestine in vitamin D dependent rickets. Pediatrics 1970, 45:364-373.
33. Balsan S., Garabedian M., Courtecuisse V., Gueris J., Dommergues J.P., Creignou L., et al. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with "pseudo-deficiency" rickets. Clin. Endocrinol. (Oxf.) 1977, 7(Suppl.):225s-230s.
34. Reade T.M., Scriver C.R., Glorieux F.H., Nogrady B., Delvin E., Poirier R., et al. Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency. Pediatr. Res. 1975, 9:593-599.
35. Dardenne O., Prud'homme J., Glorieux F.H., St-Arnaud R. Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice. J. Steroid Biochem. Mol. Biol. 2004, 89-90:327-330.
36. Vigano P., Lattuada D., Mangioni S., Ermellino L., Vignali M., Caporizzo E., et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J. Mol. Endocrinol. 2006, 36:415-424.
37. Delvin E.E., Arabian A., Glorieux F.H., Mamer O.A. In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J. Clin. Endocrinol. Metab. 1985, 60:880-885.